Effects of canagliflozin on the hepatic steatosis, adipose tissue and skeletal muscle in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease / non-alcoholic steatohepatitis - Effects of canagliflozin on hepatic steatosis, adipose tissue and skeletal muscle in patients with Type 2 diabetes mellitus with NAFLD/NASH

Yokohama City University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2015年8月28日最近更新: 2023年10月17日

试验速览

暂无简介。

•-Patients corresponding to any of the following are inapplicable -Patients with a history of allergy to any component of the study medications -Patients with severe ketosis or diabetic coma. -Patients with severe infections, perioperative status, or severe trauma -Patients with severe complications( liver disease, renal disease, mental disorder, cancer) -Patients that we may be running out of plasticity of enforcement for image or analysis of the examination, for example, remarkable spinal column scoliosis -Patients who has difficulty in MRI study implementation including having a Implantable cardioverter-defibrillator and internal metal et al -Pregnancy or lactation in women -Inadequacy of usingig this therapy

发起方

Yokohama City University Graduate School of Medicine